
Women survivors of breast cancer are at a higher risk of developing heart disease, reports a new study.
Thanks to advanced medical treatments, women diagnosed with breast cancer today will likely survive the disease. However, some treatment options put these women at greater risk for a number of other health problems.
Advertisement
‘Postmenopausal women and women treated for breast cancer are more likely to develop heart disease than those not diagnosed with breast cancer.’
Read More..
Tweet it Now
Read More..
A new study out of Brazil shows that postmenopausal women with breast cancer are at greater risk for developing heart disease. Results are published online in Menopause, the journal of The North American Menopause Society (NAMS).
Cardiovascular disease remains the main cause of death in postmenopausal women, and women treated for breast cancer are at greater risk of developing heart disease than those not diagnosed with breast cancer. These cardiovascular effects may occur more than 5 years after radiation exposure, with the risk persisting for up to 30 years.
The goal of the new study was to compare and evaluate risk factors for cardiovascular disease in postmenopausal women who are survivors of breast cancer and women without breast cancer.
The research team found that postmenopausal women who are survivors of breast cancer showed a markedly stronger association with metabolic syndrome, diabetes, atherosclerosis, hypertriglyceridemia, and abdominal obesity, which are major risk factors for cardiovascular disease. The risk of cardiovascular mortality similarly increased to match death rates from cancer itself.
Findings were published in the article "High risk for cardiovascular disease in postmenopausal breast cancer survivors."
"Heart disease appears more commonly in women treated for breast cancer because of the toxicities of chemotherapy, radiation therapy, and the use of aromatase inhibitors, which lower estrogen. Heart-healthy lifestyle modifications will decrease both the risk of recurrent breast cancer and the risk of developing heart disease," says Dr. JoAnn Pinkerton, NAMS executive director. "Women should schedule a cardiology consultation when breast cancer is diagnosed and continue with ongoing follow-up after cancer treatments are completed."
Source: Eurekalert
Advertisement
The goal of the new study was to compare and evaluate risk factors for cardiovascular disease in postmenopausal women who are survivors of breast cancer and women without breast cancer.
The research team found that postmenopausal women who are survivors of breast cancer showed a markedly stronger association with metabolic syndrome, diabetes, atherosclerosis, hypertriglyceridemia, and abdominal obesity, which are major risk factors for cardiovascular disease. The risk of cardiovascular mortality similarly increased to match death rates from cancer itself.
Findings were published in the article "High risk for cardiovascular disease in postmenopausal breast cancer survivors."
"Heart disease appears more commonly in women treated for breast cancer because of the toxicities of chemotherapy, radiation therapy, and the use of aromatase inhibitors, which lower estrogen. Heart-healthy lifestyle modifications will decrease both the risk of recurrent breast cancer and the risk of developing heart disease," says Dr. JoAnn Pinkerton, NAMS executive director. "Women should schedule a cardiology consultation when breast cancer is diagnosed and continue with ongoing follow-up after cancer treatments are completed."
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News

In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.

An antibody treatment helped shrink tumors in some patients with bile duct cancers.

Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.

The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.

The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.